There's a Best Option for Patients With Head-and-Neck Cancer Who Can't Take Cisplatin

TUESDAY, Nov. 26, 2024 -- Cisplatin is the go-to chemotherapy for people battling head-and-neck cancers, but nearly a third of patients can't tolerate its side effects and quit the drug.

A new trial offers surprising results on the best second-line...